JP2016527186A5 - - Google Patents

Download PDF

Info

Publication number
JP2016527186A5
JP2016527186A5 JP2016514479A JP2016514479A JP2016527186A5 JP 2016527186 A5 JP2016527186 A5 JP 2016527186A5 JP 2016514479 A JP2016514479 A JP 2016514479A JP 2016514479 A JP2016514479 A JP 2016514479A JP 2016527186 A5 JP2016527186 A5 JP 2016527186A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
independently
group
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016514479A
Other languages
English (en)
Japanese (ja)
Other versions
JP6643758B2 (ja
JP2016527186A (ja
Filing date
Publication date
Priority claimed from GB201309248A external-priority patent/GB201309248D0/en
Priority claimed from GB201404301A external-priority patent/GB201404301D0/en
Application filed filed Critical
Priority claimed from PCT/GB2014/051547 external-priority patent/WO2014188178A1/en
Publication of JP2016527186A publication Critical patent/JP2016527186A/ja
Publication of JP2016527186A5 publication Critical patent/JP2016527186A5/ja
Application granted granted Critical
Publication of JP6643758B2 publication Critical patent/JP6643758B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016514479A 2013-05-22 2014-05-21 異なった抗生物質と一緒の組合せ療法におけるポリミキシン誘導体及びその使用 Active JP6643758B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB201309248A GB201309248D0 (en) 2013-05-22 2013-05-22 Compounds and combinations
GB1309248.1 2013-05-22
GB201404301A GB201404301D0 (en) 2014-03-11 2014-03-11 Compounds and combinations
GB1404301.2 2014-03-11
PCT/GB2014/051547 WO2014188178A1 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics

Publications (3)

Publication Number Publication Date
JP2016527186A JP2016527186A (ja) 2016-09-08
JP2016527186A5 true JP2016527186A5 (https=) 2017-07-20
JP6643758B2 JP6643758B2 (ja) 2020-02-12

Family

ID=50829204

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016514479A Active JP6643758B2 (ja) 2013-05-22 2014-05-21 異なった抗生物質と一緒の組合せ療法におけるポリミキシン誘導体及びその使用

Country Status (20)

Country Link
US (1) US10407467B2 (https=)
EP (1) EP2999711B1 (https=)
JP (1) JP6643758B2 (https=)
KR (1) KR102354902B1 (https=)
CN (1) CN105308065B (https=)
BR (1) BR112015029309A2 (https=)
CA (1) CA2939061C (https=)
CY (1) CY1125479T1 (https=)
DK (1) DK2999711T3 (https=)
ES (1) ES2923762T3 (https=)
HR (1) HRP20220898T1 (https=)
HU (1) HUE059544T2 (https=)
LT (1) LT2999711T (https=)
PL (1) PL2999711T3 (https=)
PT (1) PT2999711T (https=)
RS (1) RS63484B1 (https=)
RU (1) RU2730012C2 (https=)
SI (1) SI2999711T1 (https=)
TW (1) TWI665218B (https=)
WO (1) WO2014188178A1 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2855916A1 (en) * 2011-11-18 2013-05-23 Novacta Biosystems Limited Polymyxin derivatives
KR102354902B1 (ko) 2013-05-22 2022-01-24 에버레스트 메디신즈 (싱가포르) 피티이. 리미티드 폴리믹신 유도체 및 상이한 항생제와의 조합 요법에 있어서의 이들의 용도
WO2015031579A2 (en) 2013-08-28 2015-03-05 The Medicines Company Methods for treating bacterial infections using oritavancin and polymyxins
MX359104B (es) * 2014-03-11 2018-09-14 New Pharma Licence Holdings Ltd Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos.
US12146004B2 (en) 2014-11-26 2024-11-19 Spero Therapeutics, Inc. Polymyxin compounds and uses thereof
WO2016100578A2 (en) 2014-12-16 2016-06-23 Micurx Pharmaceuticals, Inc. Antimicrobial polymyxins for treatment of bacterial infections
FI126143B (en) 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
US9763996B2 (en) 2015-01-16 2017-09-19 Northern Antibiotics, Ltd. Polymyxin derivative and uses thereof
KR101790296B1 (ko) * 2015-03-26 2017-10-26 한국생명공학연구원 네트롭신을 유효성분으로 포함하는 그람음성 세균에 대한 폴리믹신의 항균 활성을 증가시키는 조성물
WO2016166103A1 (en) * 2015-04-13 2016-10-20 Xellia Pharmaceuticals Aps Polymyxin derivatives
EP3356387B1 (en) * 2015-09-29 2024-06-26 Monash University Antimicrobial polymyxin derivative compounds
JP7072898B2 (ja) * 2016-08-16 2022-05-23 ユニバーシティ オブ ロチェスター ポリミキシンb/トリメトプリム系の治療薬を含有する医薬組成物
CN106631902A (zh) * 2016-09-23 2017-05-10 上海步越化工科技有限公司 一种特拉万星侧链癸基(2‑氧代乙基)氨基甲酸9h‑芴‑9‑甲基酯的制备方法
US11191773B2 (en) 2017-07-17 2021-12-07 President And Fellows Of Harvard College Methods of treatment for bacterial infections
WO2019085926A1 (zh) * 2017-10-31 2019-05-09 上海医药工业研究院 多黏菌素类似物及其制备方法
CN111527100A (zh) 2017-11-02 2020-08-11 昆士兰大学 肽类抗生素
US11713335B2 (en) 2018-03-12 2023-08-01 President And Fellows Of Harvard College Aminocoumarin compounds and methods of their use
RS65128B1 (sr) 2018-06-25 2024-02-29 Spero Therapeutics Inc Jedinjenja
CN111690040A (zh) * 2019-03-12 2020-09-22 上海来益生物药物研究开发中心有限责任公司 多粘菌素衍生物、其制备方法和应用
CN110179967A (zh) * 2019-05-28 2019-08-30 中国医药集团总公司四川抗菌素工业研究所 多粘菌素母核和一种抗生素的组合物及其应用
WO2021150792A1 (en) 2020-01-21 2021-07-29 Micurx Pharmaceuticals, Inc. Novel compounds and composition for targeted therapy of kidney-associated cancers
US20220395555A1 (en) * 2020-06-11 2022-12-15 Boris Farber Derivatives of antibiotics
CN116437929B (zh) * 2020-07-02 2025-11-11 普渡研究基金会 抗微生物化合物的吸入制剂
WO2022098950A1 (en) 2020-11-06 2022-05-12 Spero Therapeutics, Inc. Compounds
JP7621502B2 (ja) * 2021-02-02 2025-01-24 コリア リサーチ インスティテュート オブ バイオサイエンス アンド バイオテクノロジー ビフェニル誘導体化合物を有効成分として含有する抗菌補助剤及びこの用途
JP2024525589A (ja) 2021-07-09 2024-07-12 アリゴス セラピューティクス インコーポレイテッド 抗ウイルス化合物
WO2023043816A1 (en) 2021-09-17 2023-03-23 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
WO2024003042A1 (en) 2022-06-28 2024-01-04 Breakthrough Biotech Drift Aps Novel combinations of sesquiterpene alcohols, polymyxins and nisin compounds as antimicobial and/or antifungal compounds
EP4611762A1 (en) * 2022-11-14 2025-09-10 Cipla Limited Novel ophthalmic composition
CN116212004A (zh) * 2022-12-07 2023-06-06 东南大学 一种复合抗生素吸入用粉剂及其制备方法与应用
AU2024315262A1 (en) * 2023-08-03 2026-02-26 Arcum Vision Inc. Enhanced formulation of polymyxin b/ trimethoprim and rifampin and methods for ophthalmic uses
KR20250037611A (ko) * 2023-09-07 2025-03-18 웰펩 주식회사 그람 음성균 및 다제내성 그람 음성균에 우수한 항균 활성을 갖는 신규 폴리믹신 유사체, 이를 포함하는 항균용 조성물
WO2025236916A1 (en) * 2024-05-16 2025-11-20 Brii Biosciences, Inc. Compositions and methods for treating infections

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128617A (en) 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
AU7753787A (en) 1986-08-06 1988-02-24 Jean-Luc Fauchere Production of covalent-linked conjugates from an antibiotic and a non-toxic derivative of polymyxine b
US20010021697A1 (en) 1987-09-14 2001-09-13 Henning Lowenstein Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinageous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
TW274552B (https=) 1992-05-26 1996-04-21 Hoechst Ag
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
JP4583559B2 (ja) * 2000-07-24 2010-11-17 栄研化学株式会社 Mrsaスクリーニング用培地
CA2540742A1 (en) 2003-09-30 2005-04-14 Terry Hicks Compositions and methods for treating burns
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
WO2008001773A1 (fr) 2006-06-27 2008-01-03 Toyo Tire & Rubber Co., Ltd. pneu apte à rouler dégonflé
BRPI0715095B8 (pt) 2006-08-11 2021-05-25 Northern Antibiotics Oy derivado de polimixina da fórmula geral (i); produto de combinação; composição farmacêutica; método para se sensibilizar bactérias gram-negativas a um agente antibacteriano; método para o desenvolvimento de antibióticos; método para a redução da toxicidade de polimixinas, octapeptinas naturais e seus derivados durante a aplicação das mesmas no tratamento de infecções em um indivíduo; método para melhorar as propriedades farmacocinéticas, de polimixinas, octapeptinas naturais e seus derivados; método para a sensibilização de bactérias gram-negativas clinicamente importantes a um complemento de mecanismo de defesa presente no soro; uso de um derivado; e processo para a preparação de um derivado de polimixina da fórmula (i).
US8193148B2 (en) 2008-02-08 2012-06-05 Northern Antibiotics Ltd. Short fatty acid tail polymyxin derivatives and uses thereof
US8329645B2 (en) 2008-02-08 2012-12-11 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
FI20085469A0 (fi) 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
ES2334547B1 (es) 2008-09-10 2010-12-03 Universidad De Barcelona Compuestos peptidicos antibacterianos.
CA2747995A1 (en) * 2008-12-23 2010-07-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
JP5493387B2 (ja) * 2009-02-25 2014-05-14 国立大学法人 東京大学 選択培地の製造方法及びその利用
CN101851270A (zh) 2009-04-03 2010-10-06 梁浩 一种多粘菌素衍生物及其制备方法
WO2010130007A1 (en) 2009-05-14 2010-11-18 Monash University Antimicrobial compounds
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (en) 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
US9226786B2 (en) * 2011-03-22 2016-01-05 Lexion Medical Llc Medical devices for clearing a surgical site
WO2012168820A1 (en) * 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
CA2855916A1 (en) 2011-11-18 2013-05-23 Novacta Biosystems Limited Polymyxin derivatives
KR102354902B1 (ko) 2013-05-22 2022-01-24 에버레스트 메디신즈 (싱가포르) 피티이. 리미티드 폴리믹신 유도체 및 상이한 항생제와의 조합 요법에 있어서의 이들의 용도
JP2017512818A (ja) 2014-04-01 2017-05-25 モナシュ、ユニバーシティMonash University 抗菌性化合物としてのポリミキシン誘導体

Similar Documents

Publication Publication Date Title
JP2016527186A5 (https=)
RU2015148032A (ru) Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками
WO2023078021A1 (en) Bcma monoclonal antibody and the antibody-drug conjugate
US12161690B2 (en) Glycopeptide compositions
RU2012108874A (ru) Композиции, содержащие расщепляемые ферментами опиоидные пролекарства с модифицированным кетоном и их дополнительные ингибиторы
JP2012512898A (ja) ジペプチド結合薬用剤
JP2013533864A5 (https=)
DD158238A5 (de) Verfahren zur herstellung eines neuen inhibitors fuer das angiotensin umwandelnde enzym
MY201355A (en) "compositions comprising amino acids for use in the prevention and treatment of liver diseases"
WO2011038066A4 (en) Novel npr-b agonists
EP1878429A1 (en) Trenadermal absorption preparation
CN110582506A (zh) 新抗菌产品
EP3823630A1 (en) Peptides for activation of cell signaling in osteoprogenitor cells
KR20220041152A (ko) 뼈-결합 화합물
CN1633300A (zh) 透皮制剂
RU2013102588A (ru) Новые октапептидные соединения и их терапевтическое применение
CA2549890A1 (en) Mri contrast medium composition for oral administration
WO2000027374B1 (en) The use of excitatory amino acid transporter inhibitors to reduce cns white matter injury
US20250064955A1 (en) Drug conjugates and methods of preparing and using the same
CN109476704B (zh) 抗菌环脂肽
EP4304721A1 (en) Stapled antimicrobial peptides (stamps) and uses thereof
HK40115431A (zh) 药物偶联物及其制备与使用方法
JPWO2023275357A5 (https=)